NEOGAP Therapeutics AB Revenue and Competitors
Employee Data
- NEOGAP Therapeutics AB has 27 Employees.
- NEOGAP Therapeutics AB grew their employee count by 13% last year.
NEOGAP Therapeutics AB's People
| Name | Title | Email/Phone |
|---|
NEOGAP Therapeutics AB Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | N/A | 16 | 7% | N/A | N/A |
#2 | N/A | 27 | 13% | N/A | N/A |
#3 | N/A | 128 | 20% | N/A | N/A |
#4 | N/A | 23 | 44% | N/A | N/A |
What Is NEOGAP Therapeutics AB?
NEOGAP Therapeutics AB is a privately held clinical stage biopharmaceutical company with the main focus on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund. We are located at Therapeutic Immune Design, Centre for Molecular Medicine at Karolinska Institute, Stockholm, Sweden. \n\nOur vision is to increase overall survival among patients with cancer by boosting tumour-specific responses of the immune system. \n\nOur mission is to become an important player in the battle against cancer by development and commercialisation of our innovative cancer immunotherapy.
keywords:N/A
N/A
Total Funding
27
Number of Employees
N/A
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Stockholm
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.9M | 27 | 0% | N/A |
#2 | N/A | 27 | 59% | N/A |
#3 | $3.9M | 27 | -23% | N/A |
#4 | $4.6M | 27 | -4% | N/A |
#5 | $1.9M | 27 | 23% | N/A |